수면무호흡증 기기 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Sleep Apnea Devices Market, valued at USD 7.2 billion in 2024, is set to grow at a CAGR of 7.8% from 2025 to 2034. This growth is driven by the rising prevalence of sleep apnea and related health conditions, along with increasing awareness of the disorder and its health implications. Millions worldwide are affected by sleep apnea, but a large number of cases remain undiagnosed. Key factors contributing to the rising prevalence include aging populations, higher obesity rates, and changes in lifestyle patterns. Untreated sleep apnea is linked to serious health risks such as cardiovascular disease and diabetes, prompting more individuals to seek medical intervention. Enhanced awareness and diagnosis have spurred demand for advanced sleep apnea devices, which help manage the condition effectively.

Sleep apnea devices are designed to ensure uninterrupted breathing during sleep, reducing associated health risks and improving quality of life. These devices include therapeutic solutions like CPAP and BiPAP machines, which remain the top choice for managing obstructive sleep apnea. CPAP machines provide a steady airflow to maintain open airways, while BiPAP devices offer adjustable pressures for more complex cases. Continuous advancements in device technology, including quieter operations and enhanced comfort, have increased patient adherence to treatment. Improved compliance with these therapies supports long term management of sleep apnea, driving higher sales and bolstering the market.

The market is segmented by product into diagnostics and therapeutics, with therapeutics generating the highest revenue of USD 4.6 billion in 2024. By end use, the market is divided into home care settings and individuals, as well as sleep laboratories and hospitals. The home care segment dominated in 2024 and is projected to reach USD 8.9 billion by 2034. Home-based treatment options are gaining popularity due to their cost-effectiveness and accessibility. Patients can avoid the expenses associated with hospital visits while benefiting from affordable and insurance-supported devices. The adoption of telemedicine further enhances the appeal of home care by enabling remote monitoring and personalized adjustments to therapy. This integration of remote technologies has made home-based treatments more efficient and convenient.

The US market accounted for USD 2.5 billion in revenue in 2024, with an anticipated CAGR of 7.4% through 2034. Growth in the private healthcare sector, along with increased access to advanced diagnostic and therapeutic solutions, is fueling demand. Private healthcare providers, known for quicker services and state-of-the-art treatments, play a crucial role in the market's expansion.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of sleep apnea and related comorbidities
    • 3.2.1.2 Growing demand for portable, high-performance sleep apnea solutions
    • 3.2.1.3 Surging awareness of sleep apnea and sleep disorders
    • 3.2.1.4 Rising aging population amplifying demand
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of adherence to sleep apnea treatment
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Future market trends
• 3.6 Gap analysis
• 3.7 Regulatory landscape
• 3.8 Reimbursement scenario
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Company market share analysis
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Therapeutics
  • 5.2.1 Airway clearance systems
  • 5.2.2 Positive airway pressure (PAP) devices
    • 5.2.2.1 Continuous positive airway pressure (CPAP) devices
    • 5.2.2.2 Bilevel positive airway pressure (BiPAP) devices
    • 5.2.2.3 Automatic positive airway pressure (APAP) devices
  • 5.2.3 Adaptive servo-ventilation (ASV) devices
  • 5.2.4 Oral appliances
    • 5.2.4.1 Mandibular advancement devices
    • 5.2.4.2 Tongue-retaining devices
    • 5.2.4.3 Rapid maxillary expansion
    • 5.2.4.4 Mouth guards
  • 5.2.5 Other therapeutics
• 5.3 Diagnostics
  • 5.3.1 Polysomnography (PSG) device
    • 5.3.1.1 Ambulatory PSG devices
    • 5.3.1.2 Clinical PSG devices
  • 5.3.2 Actigraphy systems
  • 5.3.3 Pulse oximeters
  • 5.3.4 Home sleep testing (HST) devices
    • 5.3.4.1 Type 2
    • 5.3.4.2 Type 3
    • 5.3.4.3 Type 4
  • 5.3.5 Respiratory polygraph

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Home care settings and individuals
• 6.3 Sleep laboratories and hospitals

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Asahi KASEI
• 8.2 BMC
• 8.3 Cadwell
• 8.4 Drive DeVilbiss
• 8.5 FISHER & PAYKEL
• 8.6 Itamar Medical
• 8.7 Philips
• 8.8 LivaNova
• 8.9 natus
• 8.10 NIHON KOHDEN
• 8.11 ResMed
• 8.12 Teleflex
• 8.13 WEINMANN